Currently, there are several treatment options for the disease.
(1) Acute treatment: High-dose hormone shocks and plasma replacement are available. Hormone shock treatment is not expensive and has the advantage of fast onset of action, which is the classical treatment plan, but repeatedly used in large quantities, side effects such as osteoporosis, femoral head necrosis, obesity and infection may occur; plasma replacement is relatively more expensive, but the adverse effects are smaller and the efficacy is certain. For patients with severe disease, hormone shock combined with plasma replacement can be used. In addition, intravenous infusion of gammaglobulin treatment has some effectiveness, but still needs more evidence to support.
(2) Treatment in remission: Immunosuppression is recommended to prevent relapse. There are various types of immunosuppressants; traditional immunosuppressants, such as azathioprine and methotrexate, are less costly but may have greater side effects, and azathioprine is slow to take effect, taking 3 to 6 months; newer immunosuppressants, such as morte-macrolide, and biologics, such as rituximab, are relatively costly and need to be selected based on the risk of relapse and combined with economic circumstances.